The retina contains specialized photoreceptor cells known as rods and cones, which are responsible for detecting light and transmitting visual information to the brain. In dogs affected by Stargardt Disease, harmful metabolic byproducts accumulate within retinal cells due to defects in normal cellular processing. This accumulation gradually damages retinal tissues, reducing their ability to function properly and leading to progressive vision loss.
Clinical signs of STGD may develop gradually and can vary depending on the severity of the mutation and the individual dog. Early symptoms often include reduced visual acuity, difficulty seeing in certain lighting conditions, reluctance to navigate unfamiliar environments, and decreased ability to track moving objects. As the disease progresses, affected dogs may experience worsening vision, increased difficulty recognizing obstacles, and reduced confidence during movement. In advanced cases, substantial vision loss or blindness may occur. Although STGD affects vision, it is generally not painful, and many dogs adapt well to gradual changes in their sight.
The STGD DNA Health Test is designed to detect the specific genetic mutation associated with Stargardt Disease. Testing is simple and non-invasive, typically requiring a cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine the dog's genetic status. Because the test examines inherited DNA directly, it can be performed at any age, including in puppies before clinical signs become apparent.
Results are generally reported in one of three categories:
- Clear (Normal): The dog does not carry the STGD mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation but is typically unaffected by the disease. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Stargardt Disease and its associated retinal changes.
Genetic testing for STGD provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that help reduce the prevalence of the disorder while maintaining healthy genetic diversity within the breed population. Avoiding the breeding of two carrier dogs significantly decreases the risk of producing affected puppies.
For dog owners, understanding a dog's genetic status allows for proactive eye health monitoring and regular veterinary ophthalmic examinations. Dogs identified as at risk may benefit from periodic retinal evaluations to monitor disease progression and detect vision changes at an early stage. While there is currently no cure for Stargardt Disease, early diagnosis can help owners prepare for future visual impairment and make environmental adjustments that support their dog's safety and quality of life.
The Stargardt Disease (STGD) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine eye health, and helps reduce the impact of this inherited retinal disorder in future generations. Through early detection and informed breeding decisions, breeders and owners can contribute to healthier dogs and improved long-term welfare.
